Saint Luke's Newsroom

Thumbnail
May. 1, 2017

NPR: A Lazarus Patient And The Limits Of A Lifesaving Stroke Procedure

Doctors thread a catheter that holds a tiny net from the groin to the brain and "capture" the clot. The instant result some patients experience is referred to as a "Lazarus" effect.
Thumbnail
Apr. 22, 2017

KCTV: New drug gives multiple sclerosis patients a new option

There is a new hope for patients who have primary progressive multiple sclerosis.
Thumbnail
Apr. 20, 2017

FOX4: Patient Receives New Heart and is Given Second Chance at Life on Easter Weekend

After living with an enlarged heart for more than 15 years, it took Nate just 16 days to receive a new heart and it came just in time. Read his story.
Apr. 20, 2017

KCTV: Boy saves mother's life after suffering brain aneurysm

A mother adopts two children but didn’t know she would soon call one of those boys her special hero. The quick thinking of her new son helped save her life after suffering an aneurysm.
Thumbnail
Apr. 19, 2017

KSHB: Tech restores hearing for Kansas City teen

Imagine living most of your life without hearing. One teen has done just that, but things are about to change. Watch her get her coclear implant turned on for the first time.
Thumbnail
Apr. 12, 2017

KSHB: Doctors warn about the dangers athletes face

Sudden cardiac arrest strikes about 100 male and female athletes each year.

Thumbnail
Apr. 4, 2017

Kansas City Star: ECMO helps save a young girls' life

ECMO is used for patients with life-threatening heart or lung disease or damage. It provides short-term support of the cardiac or pulmonary system when conventional management fails.
Thumbnail
Mar. 24, 2017

KCTV: Flowers donated to Saint Luke's Hospice House

Local florist brightens patients and families days by donates bouquets to Saint Luke's Hospice House. 
Thumbnail
Mar. 20, 2017

Newer Type 2 Diabetes Drugs Show Heart Protective Quality in Study

A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a real world study sponsored by AstraZeneca.